ImpediMed Limited
IPDQF
$0.01
$0.00-17.65%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 20.60% | 20.21% | 21.55% | 15.15% | 8.75% |
| Total Other Revenue | -- | -- | -- | -350.00% | -348.85% |
| Total Revenue | 20.60% | 20.21% | 21.55% | 15.41% | 9.25% |
| Cost of Revenue | 37.65% | 33.54% | 30.89% | 15.82% | 1.46% |
| Gross Profit | 18.26% | 18.33% | 20.19% | 15.36% | 10.42% |
| SG&A Expenses | 5.12% | -0.63% | -4.62% | -7.51% | -10.41% |
| Depreciation & Amortization | 32.21% | 58.16% | 99.87% | 64.37% | 32.30% |
| Other Operating Expenses | -18.10% | -5.84% | 12.90% | 37.02% | 64.23% |
| Total Operating Expenses | 5.58% | 4.86% | 5.61% | 2.97% | 0.23% |
| Operating Income | 2.21% | 2.54% | 1.52% | 2.65% | 3.88% |
| Income Before Tax | -12.26% | -13.20% | -15.87% | -12.25% | -8.47% |
| Income Tax Expenses | 17.61% | -5.85% | -22.22% | -18.50% | -13.59% |
| Earnings from Continuing Operations | -12.27% | -13.18% | -15.81% | -12.20% | -8.44% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -12.27% | -13.18% | -15.81% | -12.20% | -8.44% |
| EBIT | 2.21% | 2.54% | 1.52% | 2.65% | 3.88% |
| EBITDA | 2.61% | 5.59% | 7.20% | 8.45% | 9.01% |
| EPS Basic | -14.71% | -15.15% | -15.63% | -7.58% | 0.00% |
| Normalized Basic EPS | -11.63% | -6.82% | -6.82% | 0.00% | 6.52% |
| EPS Diluted | -14.71% | -15.15% | -15.63% | -7.58% | 0.00% |
| Normalized Diluted EPS | -11.63% | -6.82% | -6.82% | 0.00% | 6.52% |
| Average Basic Shares Outstanding | 0.07% | -0.03% | -0.13% | 2.56% | 5.39% |
| Average Diluted Shares Outstanding | 0.07% | -0.03% | -0.13% | 2.56% | 5.39% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |